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Alterations of Germ Cells Leading To
Mutagenesis and Their Detection
by David J. Brusick*
Germ cell risk is an essential component of estimating the deleterious results of environmental muta-
gens. The present set of in vivo model systems appears to have limited ability to measure germ ceOl risk
from all types ofgenetic lesions. The assays most practical for use in genetic testing measure the induction
ofchromosome alterations but not specific locus gene mutations. Quantitative estimation ofgerm ceOl risk
based on such available assays is diMcult to make and may lead to incorrect assumptions ofrisk. Better
assessmentofgerm cell genetic damage will require expansion ofpresent procedures to increasesensitivity
and the development of improved assay systems.
This paper is primarily an analysis of risk assess-
ment using the types of assays which are currently
available to us, and will attempt to describe the ge-
netic alterations that can be detected using these
systems and the significance of these alterations on
the human gene pool. A description of the model
systems, whether they are considered useful or not,
and some of the problems involved in risk assess-
ment will be noted, again trying to relate this as
much as possible to human risk assessment.
In the broadest sense, when one considers germ
cell mutation, it is possible to identify a number of
effects. Consequences such as dominant lethality,
genetically based diseases, and loss or gain of sex
chromosomes are only a few. The individual in
which germ cell mutations are induced is not actu-
ally at risk. Only the progeny ofthe organism would
be at risk. This is in contrast to the effects of
somatic mutations.
Somatic mutations are those which would be in-
duced in non-germ cell tissue and result in direct
risk to the affected individual. One potential effect
from somatic mutations would be a teratogenic (de-
velopmental alteration) alteration. If the mutation
were induced prenatally during early development,
normal cell division and differentiation might be al-
tered, resulting in a biological effect described as
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terata (1). It has also been proposed that somatic
mutation may lead to the induction of neoplasia as
well (2).
Figure 1 illustrates the potential effects of germ
and somatic mutations. Although substantial indi-
rect data show a high correlation between mutations
and cancer, there is not as much direct evidence for
the somatic mutation theory of carcinogenesis. It
appears that about 50%o ofteratogenic effects have a
hereditary basis (Table 1). The remaining discus-
sion, however, will be confined to germ cell alter-
ations and the effect that these mutations have on
subsequent generations.
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FIGURE 1. Possible mutagenic effects in mammals.
June 1978 105Table 1. Comparison of the carcinogenic, mutagenic and
teratogenic effects of several chemical classes.ab
Agent Mutagen Carcinogen Teratogen
Nitrogen mustard + + +
Cyclophosphamide + + +
Triethylenemelamine (TEM) + + +
6-Mercaptopurine + + +
Hycanthone + + +
Captan + + +
Folpet + + +
X-irradiation + + +
Cigarette smoke
(condensate products) + + (+)
Triazenes + + +
Androgenic hormones - +
Rubella virus - - +
Quinacrine (+) - +
Halothane (+) ? (+)
5-Fluorouracil - - +
Cytosine arabinoside (+) - +
Hydroxyurea - - +
Methotrexate (+) (+) +
Actinomycin D (+) - +
Benzene (+) (+) +
Urethane (+) + +
Colchicine - - +
Chlorpromazine (+) - +
a From Brusick (3).
bAmong a diverse group of recognized teratogens it can be
seen that the relationship between carcinogenic, mutagenic, and
teratogenic effects holds for only about 50o of the compounds.
The remaining agents that are teratogenic appear to act through
nongenetic mechanisms or possibly multiple mechanisms some
of which may have an indirect genetic basis. ( ) = Data ques-
tionable, conflicting, or results obtained only under very spe-
cialized treatment procedures.
What are the possible types of etfects that can
occur in germ cells? If a definition of mutation in a
broad sense of the term is used, two different
classes can be examined. One would be visible
changes (macrolesions) in chromosomes and the
other would be nonvisible (microlesions) (Fig. 2).
Macrolesions would be the type of alterations that
would be microscopically visible in the chromatin
material of the germ cells. These are detected as
either changes in chromosome numnber or as struc-
tural changes in chromosomes. Microlesions are
point mutations and these would be changes at the
molecular level, that is, alterations at the nucleotide
level of the DNA double helix.
These two classes of mutations have a very dif-
ferent impact on the gene pool of an exposed popu-
lation. Macrolesions include chromosome breaks,
gaps, fusions of chromosomes, translocations from
one part of the chromosome to another (either re-
ciprocal or nonreciprocal), deletions of chromo-
somes and also various nondisjuction effects. Ex-
cept for a few of these types such as balanced
translocations, certain types of nondisjuction ef-
fects, for example, trisomy 21, which could lead to
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FIGURE 2. Classification ofthe molecular changes in DNA which
occur as a result of mutation.
mongolism and some small deletions, macrolesicns
are not transmissible. That is, following the induc-
tion ofa macrolesion in a cell, the next cell division,
whether it be meiotic or mitotic, would normally
result in cell death due to the inability of the cell to
undergo a complete meiotic or mitotic division, to
the loss of some biochemical property because of
the deletion of a chromosome, or to a nonuniform
distribution of the chromosomes to daughter cells.
This lethality would then be expressed directly
upon the subsequent cell division or at the tirmie of
fertilization. Following fertilization, a resultant zy-
gote may be unable to undergo any further division-,
because ofthe lack ofchromosomes or because too
much chromosomal material is present. Because
macrolesions are not transmissible, they would be
expected to have little or no impact on the gene
pool, that is, our concern for detecting these types
ofmutations would be considerably less than for the
transmissible types.
The effects of macrolesions such as balanced
translocations, which could be transmitted to the F,
progeny, certain types of small deletions, and cer-
tain nondisjunction events, appear to be expressed
immediately in the F1 progeny. Nondisjuction re-
sults in some easily identifiable phenotypes, such as
in trisomy 21 (mongolism). Balanced translocations
would generally result in reduced fertility in F,
progeny so that they would also be identified. In
some cases dominant alterations may have more
phenotypic effects than just reduced fertility and
will produce other functional problems in F1 prog-
eny (4). Reduced life expectancy as well as reduced
fertility may result. Thus, macrolesions which are
transmissible can be identified very early, probably
in the next generation, and their presence would
provide a tool for assessing overall impact of
chemical mutagens on the human gene pool. There
would probably be high negative selection for these
mutations if they affected reproductive perfor-
mance. It can be concluded therefore that this class
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the human population on a long-term basis. The al-
terations represent short-term detrimental impacts
because of increased health costs associated with
fetal wastage, human miscarriage, and nondisjunc-
tional effects.
Under the class ofgenetic effects designated mi-
crolesions we have nucleotide events resulting in
base pair substitution mutations or in frameshift
mutations (5). Base-pair substitutions result in the
substitution ofone nucleotide pair for another in the
DNA helix, resulting not in any net quantitative
change in DNA, but in a qualitative change in the
nucleotide sequence which may then lead to a mu-
tation (Fig. 2). Frameshift mutations, however, re-
sul$ in net quantitative differences in the amount of
DNA by the addition or deletion of one or a small
number of nucleotides. The loss or the addition of
one or more base pairs to the DNA molecule would
result in a frameshift mutation (Fig. 2). Both types
of microlesions result in small changes in the DNA
which permit them to be transmitted without cell
death. Microlesions of the base-pair substitution or
the frameshift type can be subdivided again into two
classes designated dominant mutations or recessive
mutations. With dominant mutations the effect is
generally identified morphologically and would be
expressed in the F1 generation. A dominant muta-
tion in the F1 generation can be transmitted to the F2
generation in up to 50Wo of the offspring, but its
expression may be less, depending upon the pene-
trance ofthe gene. An affected individual can often
be recognized in the population, thus offering the
opportunity of reducing the transmission of this ef-
fect to the offspring by good genetic counseling.
Dominant mutations also serve another function;
they can be used in population monitoring (4). The
effects are expressed in the heterozygous indi-
vidual, and thus any new mutations that arise in a
given generation would be easily detected. The data
can be used to monitor that population for any
fluctuations in mutation frequencies or mutation
rates over a given chronological period. This re-
quires large-scale epidemiological investigations,
but at least it can provide information regarding the
effects of environmental mutagens.
Recessive mutations represent the true health
problem in terms ofinduced mutations. They do not
result in the immediate expression of visible muta-
tions; they will not necessarily be expressed in the
F1 or even in the F2 generation. Two mutant alleles
at the same locus are necessary to express the mu-
tant phenotype. Therefore, the induction of reces-
sive point mutations by environmental mutagens
could result in the accumulation of these mutations
in the population as heterozygotes, and it may take
many generations before they are expressed in a
homozygous state leading to increases in genetic-
based diseases. By the time such a change is evi-
dent, it would be too late to make corrective ad-
justments, and mutants would be expressed in fu-
ture generations even if the mutagens that initiated
the mutations were eliminated. Herein lies the real
problem from a long-term standpoint with respectto
the human gene pool and the vitality of human
hereditary potential.
With this as a rationale for the development of
mammalian test models, the types of mammalian
models that are available to detect mutations will be
discussed, again on emphasizing that these tests are
for detecting germ cell mutations. An attempt will
be made to show how these tests can be applied to
the problems that must be faced in terms of
monitoring the human gene pool for mutation in-
duction. There are several types of animal models
that could be used. These range from cytogenetic
investigation ofspermatogonia cells (spermatocytes
or oocytes) in treated individuals (6, 7) to large-
scale studies involving the specific locus gene mu-
tation test in mice (8). The most commonly
employed are somewhere between these two ex-
tremes. Examples of routine tests would be the
dominant lethal test (9) and the heritable transloca-
tion test (1O).
The Mouse Specific Locus Test
The specific locus test can measure, theoreti-
cally, the type of mutation that is of the most con-
cern, that is, point mutation. This technique is used
where one of the parents has a series of homozy-
gous recessive mutant alleles. The normal parent
would be exposed to the mutagen and then mated to
the homozygous recessive parent. F1 progeny
would then be looked at for the presence of one or
more of the expressing mutant alleles that could be
carried by the tester strain (Fig. 3). This can be done
either morphologically through the use ofcoat color
alleles and a number of other types of morphologi-
cal alleles in the specific locus test that was de-
veloped by Russell (8). Malling and Valcovic (11)
have developed a technique to detect
electrophoretic variants among several biochemical
mutants in mice as a specific locus test. In general,
ifthe specific locus test is employed, the size ofthe
test itselfwill be determined by the number ofgenes
that can be monitored. When measuring rare events
occurring at only a small number of targets (moni-
tored genes) a large population must be examined to
see a significant change in mutation frequency. The
number of alleles generally available in specific
locus tests with mice ranges between 5 and 10 so
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that, relatively speaking, out of the total genome of
the mouse, 5 to 10 genes represent a relatively small
group of targets, necessitating a relatively large
number of animals be examined to measure effects
that would be induced in one or more ofthese target
loci. Thus, these tests can be used to monitor for the
point locus type of mutation, but they cannot be
practically applied to the evaluation of large num-
bers ofchemicals. However, specific locus tests are
important, in that they can identify mutagens that
can produce either point mutations or small dele-
tions which are transmissible and can be verified as
such by additional matings to show that the
phenotype is a true mutation. These tests are suita-
ble for risk assessment of special chemicals. It is
difficult to establish the type of mutation definitely,
even though one can do subsequent mating experi-
ments to show that the effect is transmissible. The
verification system cannot differentiate between a
true point mutation and a small deletion. There is
also a problem involved in distinguishing mutation
from nonmutagenic events such as mitotic recombi-
nation or gene conversion events which would
mimic mutational alterations, but which would be
induced by mechanisms other than those for gene
mutation.
C57BL/
a + + + ++ +
i, _,- I _ , _
a + + + ++ +
Treat either Males
or Females with
Test Compounds
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FIGURE 3. Specific locus test.
Direct Cytological Examination of
Germ Cells
It is possible to conduct cytogenetic assays which
directly examine the germinal cell lines of exposed
male or female animals for clastogenic effects.
There is a problem in this approach if one looks at
exposed germ cells, for example spermatogonial
cells, treated with a chemical or with radiation. Ex-
periments have been conducted in which somatic
cells were compared to spermatogonia for visible
chromosomal aberrations (12, 13). In somatic cells a
certain frequency of chromosomal aberrations was
observed. When the spermatogonial cells of the
same treated animal were examined, there was a
reduction by as much as 75% in the same type of
alteration that would be induced in the somatic
cells, indicating that within the germ cell line there
is a screening mechanism which will eliminate aber-
rant cells during cell division. These cells may be
cleared out because they have reduced viability
compared to the normal cells. A similar loss of
transmissible balanced translocations in mouse
spermatogonia following x-irradiation also
suggested a meiotic screening mechanism. Thus
there appears to be a mechanism for reducing the
transmission of aberrations to the F1 progeny.
Therefore, using spermatogonia or spermatocytes
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mutagenic capability of a chemical would be very
misleading in terms of the actual quantitative ex-
pression of these types of events in F1 progeny be-
cause most of the events that would be detected
cytologically in early stage germ cells will be elimi-
nated prior to the formation of viable sperm.
Cytological examination may be a quick and inex-
pensive procedure, but it is an uncertain procedure
when one begins to extrapolate observed effects in
the treated animal with predicted effects in the F,
progeny.
Sex Chromosome Loss
Sex chromosome loss is another endpoint that is
applicable to germ cell analysis (14). This consists
ofscreening for XO individuals following treatment.
These effects would be due in most cases to non-
disjunction mechanisms. Such assays can be per-
formed quite readily by using strains with X
chromosome-linked markers, so that loss of a sex
chromosome would result in a morphological
change in the F1 progeny.
There is another assay performed with the use of
a type of field mouse, in which the sex chromatin
material is stained more densely on cytological
examination than other types of chromatin, so that
one can quickly screen with this particular animal
whether sex chromosomes have been gained or lost
from the germ cells (15).
Dominant Lethal and Heritable
Translocation Tests
Direct cytogenetic analysis and the specific locus
test are not used as frequently as the dominant le-
thal and heritable translocations assays to provide a
risk assessment for germinal cells.
The following paragraphs present a closer look at
the dominant lethal test and the heritable transloca-
tion test; these are the most widely used tests for
measuring germ cell mutations. A relatively large
body ofdata exists from these assays, and they pro-
vide in many cases the basis for current risk as-
sessment of industrial chemicals and drugs.
The dominant lethal test can be conducted in both
male and female animals, although typically it is
conducted in males. A group of males, anywhere
from 10 to 50 depending upon the design of the ex-
periment, would be treated with the chemical. Gen-
erally the animals would be treated either acutely in
a single exposure or subchronically for 5 days and
then mated sequentially to groups of virgin females
over the period of spermatogenesis. The females
would be caged with the treated males, for, in the
case of rats 5 or 6 days and in the case of mice 4
days. After mating, the females are removed, and
then at midpregnancy fertilized animals are exam-
ined for the number of living or dead embryos and
the number of implants (Fig. 4). Fetal mortality is
used as an indication ofgerm cell mutation. Pre- and
postimplantation effects can be measured.
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SEQUENTIALLY
TO VIRIGIN FEMALES
ON 4-7 DAY CAGING PERIODS EXTENDING
OVER ONE COMPLETE
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FIGURE 4. The male dominant lethal assay.
In the heritable translocation test, males are also
treated (Fig. 5). This test is generally conducted in
the mouse. The males are mated to virgin females
(two per male), but, instead of sacrificing the
females, they are allowed to litter and the F1 male
progeny are retained. These F1 males are then
mated sequentially to groups of virgin females and
an estimation of sterility or semisterility is made to
presumptively identify F1 male progeny carrying
balanced translocations. The translocation carriers,
once identified presumptively, can be verified
cytogenetically by looking at germ cells arrested in
meiotic metaphase for translocations.
In general, these are the types ofprotocols avail-
able to study germ cell risk. Evaluating the utility of
these tests with respect to meeting the following
criteria is important in adopting them as risk-
assessment tests: (a) what is the level of the
background effect; (b) what endpoints are used to
identify mutation (what types of events are de-
tected); (c) can the mutants be verified; (d) what is
the general level ofsensitivity ofthe test; (e) what is
the ability of the test to detect alterations during
different stages in the spermatogenic cycle; and (f)
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FIGURE 5. Heritable translocation diagram.
what is the transmissibility of the event and what
are the sex or strain differences. The limitations and
advantages of the dominant lethal and heritable
translocation assays will become obvious based on
these criteria.
First of all, with respect to spontaneous
background, dominant lethal tests, at least in mice,
have a background of about 6 or 7%, which is rela-
tively high. The reason that the background is rela-
tively high is that alterations in a number of differ-
ent genes can lead to dominant lethality as an end-
point. Therefore the opportunity for fetal wastage is
high even in untreated animals. In the case of herit-
able translocation, the background is relatively low;
at most about one carrier per thousand normal ani-
mals (14). This is a comparatively low background
and results because the test is measuring a very
specific type of chromosome event.
The types of events that can be detected in the
dominant lethal test will be gross chromosomal al-
terations: changes in chromosome structure,
changes in chromosome number or nondisjunction
events. In the case of the heritable translocation
test, only one type of chromosomal structural
event, a balanced translocation, is detected. The
endpoint criteria in the dominant lethal test can be
preimplantation or postimplantation loss. Pre-
implantation loss is generally derived by comparing
the total number of corpora lutea to the total
number of implants per pregnant female. The
number of implants and the number of living and
dead embryos are used in postimplantation evalua-
tion ofdominant lethality. For the heritable translo-
cation assay, the endpoint criterion would be either
sterility or semisterility in the F, males followed by
the verification of translocations by cytogenetic
techniques. Because the heritable translocation
technique is a two-generation test, verification of
the genetic origin and transmissibility ofthe effect is
possible.
Verification of the genetic origin of dominant le-
thal effects cannot be accomplished, and is one of
the limitations of this test.
The level ofsensitivity ofan assay is an important
consideration for its utilization. What magnitude of
animal numbers would one need to detect a signifi-
cant effect? Statistically, there is a sizable differ-
ence between the dominant lethal and the heritable
translocation assay. For example, using the mouse
dominant lethal test one can provide an acceptable
level of sensitivity with something like 40 male ani-
mals per treatment group, dosed and mated one
male to one female, over twelve 4-day sequences.
Approximately 12 of these sequences cover sper-
matogenesis (Fig. 4). This protocol can give a rea-
sonable level of sensitivity. A two- to threefold in-
crease over the background can be detected with a
95% level of confidence, and roughly 1100 animals
would be required. The problem is that because the
background is so high to begin with, only a potent
germ cell mutagen will lead to a two- to threefold
increase. For the heritable translocation, however,
to detect roughly an equivalent increase over the
background, one would need roughly 4600 animals
to achieve a 95% confidence level. Thus, there is a
tremendous difference, about four- to fivefold, in
terms of the number of animals to achieve compar-
able levels of sensitivity. Theoretically, however,
the heritable translocation assay might detect
weaker mutagens. The dominant lethal test is less
reliable as a genetic assay for germ cell risk assess-
ment, because it lacks verification as to the genetic
nature of the effects. The ability to verify the ge-
netic lesion in the translocation test gives it a
weighted advantage.
Detection ofcell stage specificity can be obtained
with the dominant lethal assay by sequentially
mating as outlined. Forexample, in a mouse, twelve
4-day cycles would cover the route of a cell from
speratogonia to mature sperm in the mouse. In the
heritable translocation test, the protocol specifies
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followed by a single mating period, which will not
permit any investigation into the specific cell sensi-
tive stage in spermatogenesis.
The dominant lethal test can be performed on
both males and females (16). Female dominant le-
thal tests are not done routinely simply because: (a)
the oocytes are generally less sensitive to chemicals
than sperm; and (b) one cannot easily discriminate
between cytotoxic effects and true genetic effects
particularly in preimplantation loss. Artifactual
preimplantation loss also occurs in male-treated
dominant lethal tests but would be expected to be
less than that found in the female-treated proce-
dure. Good female dominant lethal studies can be
performed by taking the time to identify the estrus
cycle in the females to be treated and then setting up
a regimen in which the treatment can be com-
menced following ovulation, so that one will be
treating more sensitive cells than the oocytes (17).
The heritable translocation test is exclusively con-
ducted in male animals. Strain differences in sen-
sitivity have been reported for both the dominant
lethal and heritable translocation assays (Generoso,
personal communication).
Both the dominant lethal and the heritable trans-
location tests have decided advantages and disad-
vantages with respect to sensitivity and general
utilization for evaluating the mutagenic effects of
chemicals. Neither ofthem, in the author's opinion,
are optimum tools to do risk assessment because
neither ofthem detect specific locus gene mutations
which are the type of alterations of major concern.
Studies in Drosophila melanogaster, where both
point mutation induction and dominant lethal ef-
fects can be scored in the same exposed population,
have shown two distinct induction curves for point
mutations and dominant lethal mutations (18). At
low concentrations ofthe test mutagens the induced
mutations were almost exclusively point mutations
(microlesions), and not until significantly high con-
centrations were dominant lethal (macrolesions) in-
duced. This may be the case in mammals as well. If
so, the mammalian assays that are used to screen
for mutagenic effects of chemicals may well pro-
duce negative results, because it may not be possi-
ble to expose the animals to sufficient concentra-
tions of the test chemical to produce dominant le-
thality (chromosomal effects). At levels of the test
material that are relatively nontoxic, the results
would appear to be negative by the dominant lethal
and translocation assays, although significant num-
bers of specific locus point mutations might have
been produced. Mutagens which induce significant
levels of point mutations would be negative in the
types of assays that we use as model systems, and
only those chemicals which are potent chromosome
mutagens will show up as positive. Among a large
group ofchemicals tested in dominant lethal assays,
specifically a group of chemicals on the GRAS list
screened by the Food and Drug Administration,
50% fell into the questionable range. That is, one
could not make either a clearly positive or a clearly
negative assessment from the particular test. This
points out another weakness of the dominant lethal
procedure as a sensitive measuring device. The in-
herent resolution ofthe technique is not good unless
large numbers ofanimals are used or the chemical is
a potent mutagen.
If there is some way to quantify the number of
point mutations that might lead to chromosomal
aberrations, then the use of the dominant lethal
assay or heritable translocation assay which mea-
sures the chromosomal aberrations would have
more reliability in assessing germ cell risk for all
types of genetic damage. Most investigators state
that the dominant lethal test is used as a signal. If
dominant lethality is observed, it can be assumed
that other types of mutations are being induced.
This may be somewhat naive, since there is no way
to relate gene mutations or other types of genetic
lesions quantitatively to dominant lethality.
Another point regarding germ cell toxicity con-
cerns negative results and the ability to measure
whether any of the administered chemical actually
reaches the germ cells. As an example, the amount
of administered dimethylnitrosamine (DMN) was
measured in the testicular fluid of a treated animal.
No alkylation of sperm DNA was measured, but
there were measurable amounts of DMN in the
testes. Most likely this observation was related to
the metabolic capacity of the testes. Certainly one
might find DMN in the testes, but DMN is not the
molecule that will alkylate DNA. The active
metabolite of DMN is an alkylating agent. Activa-
tion systems that are found in the testes are not
capable of forming the molecule that will alkylate
the DNA and produce germ cell mutations. Using
systems to radiolabel materials and then looking for
the presence of label in germ cells does not give a
true measure of whether or not a negative result is
true or false. The chemical might be present, but
there may be no biological effect of the chemical
because the testes cannot produce the necessary
bioactivation.
In conclusion, one has the choice of developing
better mammalian test systems, using submamma-
lian test systems such as Drosophila to measure
germ cell effects, or trying to gain an understanding
of the relationship between point mutation (mic-
rolesion) induction and chromosome (macrolesion)
induction in mammals. If such a relationship can be
June 1978 illquantified in some way, the accuracy and reliability
of the dominant lethal and heritable translocation
assays will be increased considerably, making these
tests, which this author now considers to be inap-
propriate models for determining risk, useful tools
in genetic toxicology.
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